Medtronic Q1 FY27 Beats, Raises Full-Year Guidance on Broad-Based Strength
MDT sits 30% above its 52-week low of $73.31.
Summary
Medtronic beat Q1 FY27 expectations with 13.7% organic revenue growth and raised full-year revenue and EPS guidance, led by an 88% surge in Cardiac Ablation Solutions.
Key Events · Earnings and Guidance · MDT
-
Q1 Revenue Beats by ~200 bps
Revenue of $9.756B grew 13.7% organic, roughly 200 basis points above the guidance midpoint, with all major portfolios posting double-digit growth.
-
Cardiac Ablation Solutions Surges 88%
Cardiac Ablation Solutions grew 88% organic, driving Cardiovascular portfolio growth of 18.9% organic.
-
Full-Year Guidance Raised
FY27 organic revenue growth guidance raised 50 bps to 7.25%-7.75%; non-GAAP diluted EPS guidance raised to $5.94-$6.00 from $5.90-$6.00.
-
Extra Week Adds ~$570M
The 53-week fiscal year's extra week in Q1 benefited organic growth by approximately $570 million, meaning underlying growth is lower than the headline 13.7%.
Analysis · MDT · Industrial Applications And Services
A strong start to fiscal 2027 saw revenue and EPS come in ahead of expectations, prompting a full-year guidance raise. Organic growth of 13.7% was roughly 200 basis points above the midpoint, fueled by an 88% surge in Cardiac Ablation Solutions and double-digit gains across all major portfolios. Management lifted FY27 organic revenue growth guidance by 50 basis points and raised the EPS range to $5.94-$6.00. The extra fiscal week added about $570 million to organic growth, so underlying momentum is slightly less than the headline suggests, but the breadth of performance and guidance raise are clear positives.
How filings like this one have moved
In the 30 days to Sep 9, 2026, 36.4% of the 1919 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MDT was trading at $95.02 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $116B. The 52-week trading range was $73.31 to $106.33. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.